Mounjaro (tirzepatide) is a prescription medication used to treat adults with type 2 diabetes, along with diet and exercise, to improve blood sugar (glucose) levels
. The active ingredient in Mounjaro is tirzepatide
. Some common side effects of Mounjaro include:
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Dyspepsia
- Abdominal pain
Mounjaro is a clear, colorless to slightly yellow, sterile, preservative-free solution for subcutaneous use, with each single-dose pen or single-dose vial containing a 0.5 mL solution of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg of tirzepatide
. The inactive ingredients in Mounjaro include sodium chloride, sodium phosphate dibasic heptahydrate, and water for injection, as well as hydrochloric acid solution and/or sodium hydroxide solution
. Mounjaro has been associated with an increased risk of thyroid cancer, and patients should be monitored for any symptoms of thyroid tumors, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath
. If you experience any of these symptoms, it is essential to consult your doctor immediately.
